US EditionPublished • loading... • Updated
Wegovy and Ozempic May Benefit Patients with Schizophrenia
Summary by medicinsketidsskrifter.dk
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PSYCHIATRIC JOURNAL Wegovy and Ozempic may benefit patients with schizophrenia A Danish study shows that semaglutide improves weight, blood sugar and quality of life in patients receiving antipsychotic treatment - without worsening schizophrenia symptoms.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
